Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02254551 |
| Title | Safety/Efficacy Study of LDE225 (Sonidegib) Plus Bortezomib in Patients With Relapsed or Relapsed/Refractory Multiple Myeloma |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | SCRI Development Innovations, LLC |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Colorado Blood Cancer Institute | Denver | Colorado | 80218 | United States | Details | |
| Oncology Hematology Care | Cincinnati | Ohio | 45236 | United States | Details | |
| Tennessee Oncology | Chattanooga | Tennessee | 37404 | United States | Details | |
| Tennessee Oncology PLLC | Nashville | Tennessee | 37203 | United States | Details | |
| Texas Transplant Institute/Methodist Healthcare | San Antonio | Texas | 78229 | United States | Details |